|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM364216255 |
| 003 |
DE-627 |
| 005 |
20240330000524.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202307822
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1355.xml
|
| 035 |
|
|
|a (DE-627)NLM364216255
|
| 035 |
|
|
|a (NLM)37929780
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Huang, Pei
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Cellular Trafficking of Nanotechnology-Mediated mRNA Delivery
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 29.03.2024
|
| 500 |
|
|
|a Date Revised 29.03.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Messenger RNA (mRNA)-based therapy has emerged as a powerful, safe, and rapidly scalable therapeutic approach that involves technologies for both mRNA itself and the delivery vehicle. Although there are some unique challenges for different applications of mRNA therapy, a common challenge for all mRNA therapeutics is the transport of mRNA into the target cell cytoplasm for sufficient protein expression. This review is focused on the behaviors at the cellular level of nanotechnology-mediated mRNA delivery systems, which have not been comprehensively reviewed yet. First, the four main therapeutic applications of mRNA are introduced, including immunotherapy, protein replacement therapy, genome editing, and cellular reprogramming. Second, common types of mRNA cargos and mRNA delivery systems are summarized. Third, strategies to enhance mRNA delivery efficiency during the cellular trafficking process are highlighted, including accumulation to the cell, internalization into the cell, endosomal escape, release of mRNA from the nanocarrier, and translation of mRNA into protein. Finally, the challenges and opportunities for the development of nanotechnology-mediated mRNA delivery systems are presented. This review can provide new insights into the future fabrication of mRNA nanocarriers with desirable cellular trafficking performance
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a cellular trafficking
|
| 650 |
|
4 |
|a endosomal escape
|
| 650 |
|
4 |
|a internalization
|
| 650 |
|
4 |
|a mRNA delivery system
|
| 650 |
|
4 |
|a mRNA translation
|
| 650 |
|
4 |
|a stimuli‐responsive release
|
| 650 |
|
4 |
|a targeted delivery
|
| 650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
| 650 |
|
7 |
|a Proteins
|2 NLM
|
| 700 |
1 |
|
|a Deng, Hongzhang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Changrong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhou, Yongfeng
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Xiaoyuan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 13 vom: 01. März, Seite e2307822
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:13
|g day:01
|g month:03
|g pages:e2307822
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202307822
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 2024
|e 13
|b 01
|c 03
|h e2307822
|